無料プレビュー

Bio-Rad Laboratories, Inc. (BIO) · New York Stock Exchange

プロフィール

Bio-Rad Laboratories is a multinational life science and clinical diagnostics company that develops, manufactures, and markets instruments, systems, reagents, and consumables for research, biopharmaceutical, and clinical laboratory applications. The Life Science segment provides products for separation, purification, characterization, and quantification of biological materials used in research and biopharmaceutical manufacturing. The Clinical Diagnostics segment supplies in vitro diagnostic test systems, reagents, instruments, and software for clinical laboratories, generating recurring revenu

主要指標

株価: $360.40 (-2.04%)
時価総額: 97億ドル
PER（今期予想）: 37.0
PBR: 1.3
配当利回り: —
52週レンジ: $236.73 – $396.23
業種: Healthcare / Medical - Devices
上場: New York Stock Exchange
構成銘柄: —

比較会社: TMO Thermo Fisher Scientific Inc.、ABT Abbott Laboratories、DHR Danaher Corporation、MDT Medtronic Plc、SYK Stryker Corporation、BSX Boston Scientific Corporation、EW Edwards Lifesciences Corporation、DXCM DexCom, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-29 · 更新: 2026-10-09